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Chronic compression of dorsal root ganglion (CCD) results in neuropathic pain. We investigated the role of spinal GABA in
CCD-induced pain using rats with unilateral CCD. A stereological analysis revealed that the proportion of GABA-immunoreactive
neurons to total neurons at L4/5 laminae I–III on the injured side decreased in the early phase of CCD (post-CCD week 1) and
then returned to the sham-control level in the late phase (post-CCD week 18). In the early phase, the rats showed an increase
in both mechanical sensitivity of the hind paw and spinal WDR neuronal excitability on the injured side, and such increase
was suppressed by spinally applied muscimol (GABA-A agonist, 5 nmol) and baclofen (GABA-B agonist, 25 nmol), indicating the
reduced spinal GABAergic inhibition involved. In the late phase, the CCD-induced increase inmechanical sensitivity and neuronal
excitability returned to pre-CCD levels, and such recovered responses were enhanced by spinally applied bicuculline (GABA-A
antagonist, 15 nmol) and CGP52432 (GABA-B antagonist, 15 nmol), indicating the regained spinal GABAergic inhibition involved.
In conclusion, the alteration of spinal GABAergic inhibition following CCD and leading to a gradual reduction over time of CCD-
induced mechanical hypersensitivity is most likely due to changes in GABA content in spinal GABA neurons.
1. Introduction
Neuropathic pain caused by diseases or injury involving
the peripheral or central nervous system has characteristic
symptoms of spontaneous burning pain, allodynia (non-
painful becomes painful), and hyperalgesia (painful becomes
increasingly painful) [1]. Clinical reports have indicated that
more than 60% of neuropathic pain patients were associated
with spinal abnormalities including spinal infections and
tumors, as well as structural changes of spinal vertebra, such
as spinal disc herniation, spinal stenosis, and intervertebral
foramen stenosis [2]. Compression of a spinal nerve induced
by structural changes of spinal vertebra leads to radicular
or low back pain that originates from the lower back and
radiates down to the back of the leg and the foot [3]. In
addition, about 40% of chronic low back pain patients are
shown to have neuropathic pain [4]. Thus, it is possible
that peripheral neuropathic pain and radicular pain share a
common underlying mechanism.
A rat model of radicular pain that has been developed
by chronic compression of the dorsal root ganglion (CCD)
demonstrates behavioral signs of neuropathic pain such as
mechanical allodynia, hyperalgesia, and enhanced excitabil-
ity of dorsal root ganglion (DRG) neurons [5–7].Themassive
impulses that originate from injured DRG neurons to the
spinal cord contribute to altered spinal synaptic plasticity
or central sensitization known as the neural mechanisms of
hyperalgesia and allodynia. One of the speculated aspects
of the underlying mechanisms in spinal central sensitiza-
tion is the decrease of spinal GABAergic inhibition, or
spinal GABAergic disinhibition, caused by the impairment of
GABAergic inhibition in the spinal cord. Although this spinal
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GABAergic disinhibition in neuropathic pain behaviors fol-
lowing peripheral nerve injury has previously been studied,
different results are reported. The cell deaths of spinal GABA
neurons were observed after injury [8–10]. However, no loss
of spinal GABA neurons after injury was detected [11–13]. In
addition, an increased GABA level in the spinal dorsal horn
was found after injury [14].
The involvement of spinal GABAergic disinhibition in
CCD-induced neuropathic pain has not been well studied.
The CCD injury model revealed that a gradual recovery of
neuropathic pain behavior occurs over time [15]. Thus, one
way to verify a spinal GABA involvement in the CCD model
is to examine the changes of spinal GABAergic inhibition,
which depends on GABA levels and GABA receptor activity,
both in the early and later phases following CCD. In the
present study, we have investigated first whether the change
in the number of GABA neurons as compared with the
total neurons in the lumbar spinal dorsal horn does exist
following CCD. Second, we have determined the effects of
pharmacological activation of spinal GABA receptors on
established mechanical hypersensitivity in the early phase, as
well as the effects of inhibition of spinal GABA receptors on
the reduced hypersensitivity in the later phase.
2. Materials and Methods
2.1. Animals and Surgery for CCD. A total of 83 male
rats (Sprague-Dawley, 180–200 g, Korea) were used in this
study and housed at an animal facility with autocontrolled
temperature, humidity, and light-dark cycles of 12 hours. All
experimental procedures were performed according to the
NIH and the Institutional Animal Care and Use Committee
of Yonsei University College of Medicine. Chronic compres-
sion of the fifth lumbar DRG was performed as previously
described [5]. Under deep anesthesia (enflurane, induction
5% and maintenance 2% in mixed oxygen gas), the back
skin and muscle were incised to expose the lumbar fifth
vertebra and intervertebral foramens. To compress the L5
DRG and nerve root, a sterilized stainless steel rod (0.7mm
diameter and 4mm length) was inserted in the space of the
fifth intervertebral foramen. After injury, the musculature
and skin were sutured. A sham operation was performed
according to the same procedures; however, the stainless steel
rod was not inserted. The postsurgical care was performed
with food and water ad libitum. Animals were allocated into
four groups: those that had received CCD injury (𝑛 = 26)
or sham operation (𝑛 = 26) 18 weeks earlier and those
with CCD one week (𝑛 = 26) or 8 weeks (𝑛 = 5) earlier.
The sham-operated, 1-week, and 18-week post-CCD groups
were subjected to studies of pharmacological responses to
GABA-related drugs, in which saline-treated controls were
used for stereological cell counting and electrophysiological
recordings. The 8-week post-CCD group included animals
used for stereological cell counting. All experiments were
performed by investigators blinded to animal treatments.
2.2. Drugs and Application. The effects of pharmacological
activation and inhibition of spinal GABA receptors on
mechanical sensitivity and WDR neuronal activity were
examined using drugs including GABA-A receptor ago-
nist muscimol (Tocris Cookson, UK) and antagonist (−)-
bicuculline methobromide (Tocris Cookson, UK) as well
as GABA-B receptor agonist baclofen (Sigma, Saint Louis,
MO, USA) and antagonist CGP52432 (Tocris Cookson, UK).
The drugs and doses were selected according to previous
studies [16–18]. All drugs were dissolved in 0.9% saline
and administered intrathecally using a lumbar puncture
for studying mechanical sensitivity changes via behavioral
assessment; alternatively, drugs were also applied topically
on the spinal cord for examining neuronal activity changes
via electrophysiological assessment. For intrathecal adminis-
tration by lumbar puncture, a 26-gauge needle attached to
a Hamilton syringe was inserted into the groove between
the T13 and L1 vertebrae and carefully advanced into the
intervertebral space, with the angle of the needle at about
10 degrees. Proper placement of the needle in the lumber
subarachnoid space was confirmed at the time of entry by a
sudden loss of resistance and a brief twitch of the muscles
of the hip and thigh. Each drug in a volume of 10 𝜇L was
administrated slowly over a 30-second period. For topical
application, drugs (10 𝜇L) were applied using a Hamilton
syringe onto the spinal cord surface near the site where the
recording electrodewas located. Datawere collected at 15min
after drug application, as this time point was empirically
determined to be the best for testing during the period of drug
efficacy (typically 5–50min).
2.3. GABA Immunohistochemistry. Under deep anesthesia
(urethane, 12.5mg/kg, i.p.), animals were perfused tran-
scardially with heparinized solution-A (50mM cacodylate
acid and 1% sodium metabisulfite), followed by solution-
B (100mM cacodylate acid, 2.5% glutaraldehyde and 1%
sodium metabisulfite). After spinal laminectomy, the L4-L5
spinal cord was dissected out, followed by postfixation for
2 h at room temperature. With the L4-L5 spinal cord blocks,
transverse sections (40 𝜇m thick) were cut using a Vibratome
(VT1000M, Leica, Germany). Two consecutive sections were
collected every 15 sections into 24-well plates containing
solution-C (50mM Tris and 1% sodium metabisulfite) for
GABA and NeuN immunostaining. In brief, free-floating
sections were pretreated in 49% solution-C, 50% methanol,
and 1% H
2
O
2
for 15min, and then washed in solution-
C (3 × 5min) and blocked in 98% solution-C and 2%
normal goat serum for 3 h. Sections were incubated with
anti-GABA (1 : 100, AB131, Millipore, Billerica, MA, USA) or
anti-NeuN (1 : 400, MAB377, Millipore, Billerica, MA, USA)
in a blocking solution for 16 h at 4∘C, and then washed in
solution-D (50mM Tris and 145mM sodium chloride, 3 ×
5min). Sections were then incubated with biotinylated goat
anti-mouse IgG (1 : 200) for 1 h. After washing in solution-
D (3 × 5min), sections were incubated with an avidin-biotin
peroxidase complex (1 : 200) for 1 h and washed in solution-
D (3 × 5min). For visualization, sections were incubated with
DAB substrate kit solution (Invitrogen, Frederick, MD, USA)
containing DAB and 0.6%H
2
O
2
for 5min, and then followed
by dehydration using 80, 90, and 100% ethyl alcohol and
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xylene. Finally, sections were mounted on slides and fixed
with permount mounting media (SP15-100 Toluene Solution
UN1294, Fisher Scientific, El paso, Texas, USA) under cover
glasses.
2.4. Computer Assisted Stereological Analysis. The total num-
ber of GABA- and NeuN-immunoreactive (ir) cells was
estimated from the immunostained sections (9–12 sections
for each cell type) using Computer Assisted Stereological
Toolbox (CAST), consisting of an imaging system (Olympus
BX-51, Melville, NY, USA) and software (CAST grid version
2.3.1.5, Olympus, Albertslund, Denmark). For counting cells,
a section superimposed by the gridmoved in stepwisemotion
to grid intersections along the step length in both 𝑥-axis and
𝑦-axis (92 × 92 𝜇m) in laminae I–III so that a particular
position of grid intersections was moved to the center of
the field of view on a monitor. The section was then viewed
under a 100x oil immersion objective on the monitor to set
the counting frame, with its size being 20% of the area of
the square with a side length of 𝑥-steps and 𝑦-steps. The
thickness of each section was determined before counting
proceeded, and counting was performed with the optical
dissector through a 20𝜇mdepth of a counting frame. Among
cells that came into focus within the 20 𝜇m height of the
optical dissector, only cells inside the counting frame plus
those that touched the left and bottom lines of the counting
frame were included for cell counts. The estimation of the
total number of cells in L4-L5 was performed using this
formula: 𝑁 = Σ𝑄 × (1/ASF) × (1/SSF) × (1/TSF), where 𝑁
is the estimated total number of cells, Σ𝑄 is the number of
counted cells, ASF is the area sampling fraction (the area of
the counting frame/the area of the sampling grid), SSF is the
section sampling fraction (the number of sections sampled
for analysis/the number of sections obtained for staining),
and TSF is the thickness sampling fraction (the thickness of
the counting frame/the thickness of the section) [19].
2.5. Behavioral Assessment. Each rat was housed and held
15min in a transparent acryl box (8 × 8 × 25 cm) on a metal
mesh to avoid environmental stress. After accommodation,
six applications of the von Frey filament (log unit 3.61–5.46,
equivalent to 0.4–26.0 g, North Coast Medical, CA, USA)
were applied at the center of the plantar surface of the hind
paw; these tests measured pawwithdrawal responses through
the biting of the filaments, head turning, and changes of body
posture. The paw withdrawal thresholds (PWTs) on filament
application were determined by the modified up-down test-
ing paradigm [20] using the formula: log (50% threshold) =
𝑋𝑓 + 𝜅𝛿, where 𝑋𝑓 is the value of the final von Frey
filament (log unit), 𝜅 represents the correction factors (from
a calibration table), and 𝛿 represents the mean differences of
log units between stimuli.
2.6. Electrophysiological Assessment. After anesthesia (ure-
thane, 12.5mg/kg, i.p.), a cannulation was performed for
induction and maintenance of skeletal muscular relaxation,
with a tracheostomy additionally performed for ventilation.
The respiration of each rat was maintained by ventilator
(CWE Inc., Ardmore, PA, USA), and CO
2
levels monitored
by CO
2
analyzer (CWE Inc., Ardmore, PA, USA) were held
stable at 3.5%–4.5%. The body temperature of the rat was
maintained at about 36-37∘C with a thermal blanket. A
laminectomy at T13–L2 was performed to expose the lumbar
enlargement, and the rat was then fixed on a stereotaxic
frame, with the exposed spinal cord covered by mineral oil
to prevent dryness and electric insults from the environment.
The dura matter, arachnoid membranes, and pia matter were
removed. For recoding the neuronal activity, wide dynamic
range (WDR) neurons in the L4-L5 spinal dorsal horns were
chosen. The reason for this choice is due to the important
role that the spinal WDR neurons are known to play in
signaling sensory-discriminative components of pain [21, 22].
Furthermore, we have previously observed that there exists
a correlation between spinal WDR neuronal responses and
nociceptive behavior in a spinal cord injury model [17]. To
examine the neuronal excitability, a single carbon filament-
filled glass microelectrode (2–4MΩ) was inserted into the
dorsal horn (depths of 100–600 𝜇m below the dorsal surface)
using a micropositioner (Narishige, Tokyo, Japan). The char-
acterization of WDR neurons was determined according to
response patterns to brushing (using a camel-hair brush),
pressing (using a large arterial clip, 100 g force, nonpainful),
and pinching (using a small arterial clip, 400 g force, painful)
stimuli. The single impulses generated from WDR neurons
and evoked for 10 sec with each stimulation were amplified
(DAM-80, World Precision Instruments, Sarasota, FL, USA),
and these amplified signals were fed to an oscilloscope for
monitoring as well as to the data acquisition system (CED
1401 plus, Cambridge Electronic Design, Cambridge, UK) for
data analysis.The single impulses that were identical in shape
and amplitude were collected using a window discriminator
(World Precision Instruments, Sarasota, FL, USA), and the
collected signals were analyzedwith Spike 2 software (Version
5.0, Cambridge ElectronicDesign, Cambridge,UK).The total
number of impulses evoked by each 10 s stimulus was used for
data analysis.
2.7. Statistical Analysis. The differences of repeated mea-
surements after a treatment from baseline were analyzed
using the Friedman repeated measures ANOVA on ranks
followed by Dunnett’s test for multiple comparisons. For the
comparison of twodifferent groups, theMann-Whitney rank-
sum test for unmatched pairs was used. For the comparison
of measurements before and after treatment, the Wilcoxon
signed rank test for matched pairs was employed. Differences
were considered statistically significant, if 𝑃 < 0.05. Data
were expressed as mean ± SE.
3. Results
3.1. Time Course of Changes in Mechanical Sensitivity of the
Hind Paw following CCD. One week after chronic compres-
sion of the fifth lumbar DRG (CCD), the paw withdrawal
thresholds (PWTs) in the injured side of the hind paw
were 2.23 ± 0.21 g and showed a significant decrease when
compared with values of pre-CCD (17.83 ± 0.16 g; 𝑃 < 0.05)
4 Neural Plasticity
Before 10 11 12 13 14 15 16 17 18
M
ec
ha
ni
ca
l t
hr
es
ho
ld
 (g
)
0
2
4
6
8
10
12
14
16
18
20
Time after CCD (weeks)
CCD injury 
1 2 3 4 5 6 7 8 9
∗
∗
∗
∗
∗ ∗ ∗
∗
∗
∗
∗
∗
∗
CCD ipsilateral (n = 26)
Sham ipsilateral (n = 26)
Figure 1: Changes inmechanical sensitivity of hind paws after CCD.
A unilateral CCD led to mechanical hypersensitivity of the affected
hind paw by showing decreased paw withdrawal thresholds. This
hypersensitivity gradually returned to the normal level by post-CCD
week 14. ∗𝑃 < 0.05 when compared with sham-operated rats.
and sham-operated groups (17 ± 0.37 g; 𝑃 < 0.05). The
decreased PWTs gradually recovered to the levels of pre-
CCD or sham-operated groups after 14 weeks after the injury
(Figure 1, 𝑃 > 0.05). On the contralateral side of the hind
paw in CCD groups, no significant changes in PWTs were
observed (data not shown).
3.2. Changes in GABA-ir Cell Numbers in the Spinal Dorsal
Horn following CCD. Figure 2 presents photographic images
for GABA-ir and NeuN-ir immunohistochemistry in the
lumbar dorsal horn. The square areas cover the lateral
portions of laminae I–III on both sides of the spinal cord,
shown in Figure 2(a). For 1-week and 8-week post-CCD
groups, GABA-ir cells in ipsilateral laminae I–III appeared
less dense than those for the sham-operated and 18-week
post-CCD groups; however, no density differences in the
contralateral laminae were observed among the four groups
(Figure 2(b)). NeuN-ir cells on both sides of laminae showed
no density differences among four groups. Typical GABA-ir
and NeuN-ir cells are seen in insets at the lower right of each
image (indicated by arrows).
To illustrate the stereological counting of GABA-ir and
NeuN-ir cells, images at six consecutive focal planes from the
top to the bottom of the dissector are shown in Figure 3(a). In
the examples shown, the dissector for sham-operated group
contained 5 GABA-ir and 9 NeuN-ir cells, and the dissector
for the 1-week post-CCD group contained 3 GABA-ir and 10
NeuN-ir cells (indicated by arrows).Mean thicknesses of cord
sections sampled for stereological counting (10 sections per a
rat, five rats per each group) were 26.7, 27.2, 27.6, and 27.3 𝜇m
for sham-operated, 1-week, 8-week, and 18-week post-CCD
groups, respectively. The total number of cell counts in L4-
L5 dorsal horn laminae I–III of each animal was estimated
according to the formula described in the Materials and
Methods section, and mean values for the four experimental
groups are presented in Figure 3(b). The total number of
GABA-ir cells significantly decreased (𝑃 < 0.05) on the
ipsilateral side to injury for both 1-week (12,468 ± 4,667) and
8-week (17,357 ± 4,424) post-CCD groups, compared with
sham-operated groups (28,159 ± 2,763), with no significant
differences on the contralateral side among the four groups.
For NeuN-positive cells, however, the total numbers did not
show significant differences.
3.3. Effects of Activation or Deactivation of Spinal GABA
Receptors on Mechanical Sensitivity. In sham-operated ani-
mals (Figure 4(a)), an intrathecal (i.t.) administration of
bicuculline (15 nmol, 𝑛 = 8) or CGP52432 (15 nmol, 𝑛 = 8)
reduced the PWTs maximally at 30min postdrug (0.92 ±
0.02 g and 5.23 ± 0.98 g, resp.) compared with predrug
controls (17.45 ± 0.50 g and 17.98 ± 0.03 g, resp.; 𝑃 < 0.05) as
well as with saline-injected controls (17.97 ± 0.02 g; 𝑛 = 10;
𝑃 < 0.05). The reduced PWTs lasted for 150min. In rats
with decreased PWTs on 1 week after CCD (Figure 4(b)),
muscimol (i.t., 5 nmol, 𝑛 = 8) or baclofen (i.t., 25 nmol,
𝑛 = 8) reversed the reduced PWTs maximally at 30min
postdrug (17.42 ± 0.37 g and 13.04 ± 2.20 g, resp.) compared
with preapplication controls (2.69 ± 0.31 g and 2.66 ± 0.24 g,
resp.;𝑃 < 0.05) as well as with saline-injected controls (3.33±
0.54 g; 𝑛 = 10; 𝑃 < 0.05). The reversion lasted for 180min.
In rats with PWTs that had recovered completely to pre-
CCD levels on 18 weeks after CCD (Figure 4(c)), bicuculline
(i.t., 15 nmol, 𝑛 = 8) or CGP52432 (i.t., 15 nmol, 𝑛 = 8)
produced amaximum reduction of PWTs at 30min postdrug
(3.83±2.04 g and 5.91±1.04 g, resp.) compared with predrug
controls (17.95 ± 0.23 g and 17.59 ± 0.36 g, resp.; 𝑃 < 0.05) as
well as with saline-injected controls (17.64 ± 0.82 g; 𝑛 = 10;
𝑃 < 0.05). The reduced PWTs lasted for 150min.
3.4. Effects of Activation or Deactivation of Spinal GABA
Receptors on Neuronal Excitability. In the sham-operated
group (Figures 5(a) and 5(b)), topical application of bicu-
culline (15 nmol, 𝑛 = 6) significantly increased responses
of spinal WDR neurons to brushing, pressing, and pinching
stimuli at 15min postdrug (364 ± 55, 443 ± 48, and 562 ± 53
spikes) compared with predrug controls (128 ± 9, 178 ± 29,
and 262 ± 28 spikes; 𝑃 < 0.05). The application of CGP52432
(15 nmol, 𝑛 = 6) also significantly increased such responses
(235 ± 20, 380 ± 27, and 517 ± 75 spikes), compared with
predrug control (128 ± 16, 183 ± 14, and 297 ± 36 spikes;
𝑃 < 0.05).This antagonism ofGABA receptors also enhanced
WDR neuronal after discharge activity.
In rats on 1 week after CCD (Figures 5(c) and 5(d)),WDR
neuronal responses to the three mechanical stimuli were
significantly enhanced under predrug conditions (245 ± 30,
374 ± 50, and 621 ± 44 spikes for premuscimol and 306 ± 35,
373±93, and 550±69 spikes for prebaclofen), compared with
those seen in the sham-operated groups (refer to values of
predrug controls in Figures 5(a) and 5(b); 𝑃 < 0.05). These
enhanced responses were suppressed by topical application
of muscimol (121 ± 42, 135 ± 16, and 171 ± 27 spikes;
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Figure 2: Representative images of GABA-ir and NeuN-ir cells in laminae I–III of the spinal dorsal horn. Photomicrographs of the areas of
the squares are presented in (a), which cover the lateral portions of laminae I–III, and are shown in (b). The GABA-ir cells in the ipsilateral
laminae I–III appear to be distributed less densely for 1-week and 8-week post-CCD groups than for sham-operated and 18-week post-CCD
groups, with no density difference in the contralateral laminae among the four groups. The NeuN-ir cells show no differences in density
between both sides of the dorsal horn laminae as well as among all four groups. Typical GABA-ir and NeuN-ir cells are seen in insets at the
lower right of each image (indicated by arrows).
5 nmol; 𝑛 = 6) and baclofen (109 ± 11, 132 ± 44, and
175 ± 46 spikes; 25 nmol; 𝑛 = 6), respectively. The WDR
neuronal after discharge activity seen in rats on 1 week
after CCD was also suppressed by this activation of GABA
receptors.
In rats on 18 weeks after CCD (Figures 5(e) and 5(f)),
WDR neuronal responses to the three mechanical stimuli
returned to the sham-control levels (refer to values of predrug
controls in Figures 5(a) and 5(b)) as seen under predrug
conditions (149 ± 7, 201 ± 14, and 294 ± 45 spikes for
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Figure 3: Quantitative analysis of GABA-ir and NeuN-ir cells by stereological cell counting. In (a), images used for stereological cell counts
are shown, taken at six consecutive focal planes from the top to the bottom of the 20 𝜇m optical dissector. The dissector contains 5 GABA-ir
and 9 NeuN-ir cells for the sham-operated group (i) and 3 GABA-ir and 10 NeuN-ir cells for the 1-week post-CCD group (ii) (indicated by
arrows). In (b), the mean numbers of cells estimated by stereological analysis from L4-L5 dorsal horn laminae I–III of individual animals
are represented in bar graphs (𝑛 = 5 rats for each group). The number of GABA-ir cells significantly decreased for both 1-week and 8-week
post-CCD groups compared with the sham-operated group, whereas no significant differences in NeuN-ir cell number were seen among all
four groups. ∗𝑃 < 0.05 when compared with sham-treated control.
prebicuculline and 167± 18, 234± 47, and 286± 41 spikes for
pre-CGP52432). These recovered responses were enhanced
by topical application of bicuculline (304 ± 21, 494 ± 45, and
567 ± 47 spikes; 15 nmol; 𝑛 = 6) and CGP52432 (283 ± 29,
458 ± 43, and 524 ± 97 spikes; 15 nmol; 𝑛 = 6), respectively.
As seen in the sham-control group, this antagonism of GABA
receptors resulted in enhancement of WDR neuronal after
discharge activity.
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Figure 4: The effects of inhibition or activation of spinal GABA receptors on mechanical sensitivity following CCD. In sham-operated rats
(a), an intrathecal (i.t.) administration of bicuculline (15 nmol) or CGP52432 (15 nmol) produced a decrease in the pawwithdrawal thresholds
(PWTs) for at least 150min.On 1week after CCD (b), an i.t. administration ofmuscimol (5 nmol) or baclofen (25 nmol) reversed the decreased
PWTs for longer than 90min. On 18 weeks after CCD (c), bicuculline (15 nmol) or CGP52432 (15 nmol) resulted in the decrease of PWTs for
at least 150min. ∗𝑃 < 0.05 when compared with saline-treated control.
4. Discussion
Previous reports have suggested that compression of the
fifth lumbar DRG caused neuropathic pain in the injured
side of the hind paw [3, 23]. In addition, we and others
have reported that decreased spinal GABAergic inhibition,
orGABAergic disinhibition, contributed to neuropathic pain,
following direct damages to the spinal cord and peripheral
nerves, respectively [17, 18, 24]. In the present study, we
suggest that the decrease of spinal GABAergic inhibition
without the decrease of neurons contributes to mechanical
hypersensitivity at the hind paw and spinal neuronal hyper-
excitability in the early phase following CCD.
Numerous studies have been performed to seek the
underlyingmechanisms of CCD-induced hyperexcitability in
the DRG and spinal nociceptive neurons that lead to neuro-
pathic pain. For instance, ectopic spontaneous and evoked
activities of CCD neurons were enhanced by activation of
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Figure 5: Continued.
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Figure 5: The effects of inhibition or activation of spinal GABA receptors on WDR neuronal activity following CCD. In sham-operated
animals, topical application of bicuculline ((a), 15 nmol) or CGP52432 ((b), 15 nmol) enhanced the activity of spinal WDR neurons evoked
by brushing, pressing, and pinching stimuli. On 1 week after CCD, topical application of muscimol ((c), 5 nmol) or baclofen ((d), 25 nmol)
attenuated the enhanced evoked activity of WDR neurons. On 18 weeks after CCD, bicuculline ((e), 15 nmol) or CGP52432 ((f), 15 nmol) led
to an increase in evoked activity ofWDR neurons. Data were expressed as themean number of spike discharges generated from a singleWDR
neuron evoked by three types of 10 s mechanical stimuli. Below each bar graph, examples of extracellular recordings of stimulus-evoked spike
discharges from a single WDR neuron (lower rows) and of peristimulus time histograms for visualizing the rate of spike discharges (upper
rows) are shown. ∗𝑃 < 0.05 when compared with predrug control.
inflammatory mediators via protein kinase A [25, 26], by
protease-activated receptor 2 (PAR2) [27, 28], by increased
sodium-channel and decreased potassium-channel activity
[29], by upregulation of chemokine receptor 2 (CCR2)
induced by monocyte chemoattractant protein-1 (MCP-1)
[30], and by activation of P2X receptors [31], respectively.
However, the implication of spinal GABAergic disinhibition
in CCD-induced neuropathic pain has not been well studied.
In previous studies, several possible explanations for
spinal GABAergic disinhibition in peripheral nerve injury-
induced neuropathic pain have been proposed. The first
possibility is a loss of GABA cells after nerve injury. Injury-
induced nerve impulses trigger massive releases of glutamate
in the spinal dorsal horn, followed by cell excitotoxicity that
results in the loss of GABAergic cells, consequently leading
to decreased GABAergic inhibitory function [8–10, 32, 33].
However, this hypothesis has been challenged; quantitative
analysis has revealed that the number of spinal GABA neu-
rons in rats with peripheral nerve injury is not different from
controls [11–13, 34]. In addition, our data showed no changes
in the total number of neurons at L4-L5 lumbar dorsal horn
laminae I–III following CCD and suggested no decrease of
GABA neurons in rats with CCD. The second proposed
explanation is the decrease of GABA synthesis. Studies on
peripheral nerve injurymodels have reported that the level of
glutamic acid decarboxylase-65 (GAD-65) decreased in the
spinal dorsal horn after peripheral nerve injury [8, 10]. Our
data, which demonstrate the decreased proportion of GABA
neurons to the total NeuN-ir cells at laminae I–III in the
early phase after CCD, agree with a proposal of nerve injury-
induced decrease of GABA synthesis, as GABA neurons
having an undetectableGABA levelmay be excluded from the
cell count. However, it remains for further studies to evaluate
whether CCD causes this decrease of GAD activity.The third
possibility is the decreased function of GABA receptors via
downregulation or decreased binding affinity without any
loss of GABA neurons. In support of this theory, previous
studies have demonstrated the decrease of GABA-A receptor
mRNA levels in primary afferent terminals after spinal nerve
ligation injury [35] as well as the decreased binding affinity
of GABA-B receptors in the spinal dorsal horn after sciatic
nerve transaction injury [36, 37].
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However, no loss of spinal GABA-A receptors has
been reported in rats with spared nerve injury [34]. Our
data indicate that spinal GABA receptor activity remains
intact after CCD, since spinal GABA receptor inactiva-
tion and activation could influence mechanical sensitiv-
ity and neuronal excitability in the early and late phases
after CCD. Our data also demonstrate a close correlation
between the time-dependent changes of spinalGABAcontent
and mechanical sensitivity following CCD, suggesting an
involvement of spinal GABAergic function in CCD-induced
neuropathic pain. In the early phase after CCD, spinally
applied GABA receptor agonists decreased CCD-induced
mechanical hypersensitivity, suggesting a reduction of spinal
GABAergic inhibition. After the return of mechanical sen-
sitivity to normal levels in the late phase, spinally applied
GABA antagonists regenerated mechanical hypersensitivity,
suggesting a regain of spinal GABAergic inhibition. We pos-
tulate the feasible mechanisms of time-dependent changes in
spinal GABAergic inhibition after CCD as follows. The DRG
compression induced by a stainless steel rod insertion into the
intervertebral foramen is the primary cause for developing
mechanical hypersensitivity of the hind paw. In the early
phase after CCD, DRG compression-induced enhancement
of sensory input triggers an increase of GABA release in
the spinal cord, where the balance between excitation and
inhibition is usually maintained. The increased spinal GABA
release may lead to the decreased GABA synthesis in spinal
GABAneurons, which results in decreased spinal GABAergic
inhibition, thus producing mechanical hypersensitivity. In
the later phase, however, the increased spinal GABA synthesis
may occur so that spinal GABAergic inhibition is regained to
reduce the CCD-induced mechanical hypersensitivity.
Since our knowledge of spinal synaptic circuits that
include inhibitory (mostly GABAergic/glycinergic) and exci-
tatory (mostly glutamatergic) interneurons is limited, it
is difficult to explain why spinal GABAergic neurons are
vulnerable to CCD. As proposed in the gate control theory
of pain [38], inputs from nociceptive and low-threshold (LT)
primary afferents converge onto a dorsal horn projectionneu-
ron for pain signal transmission to the brain. In this proposal,
the LT input also activates an inhibitory interneuron that
produces postsynaptic inhibition of the projection neuron
and the presynaptic inhibition of LT input. In addition,
the nociceptive input to the projection neuron is disynaptic
through an excitatory interneuron. Although the projection
neuron responds to both nociceptive and LT inputs, the effec-
tiveness of the LT input is normally reduced by the inhibitory
interneuron activity. If this inhibitory action is disrupted,
the LT input leads to stronger excitation of the projection
neuron, which has been shown in this study. A previous
study has revealed a high incidence of spontaneous ectopic
discharge that is generated after CCD from large-sized
DRG neurons of the injured ganglion [39]. This observation
suggests that inhibitory transmission is more affected than
excitatory transmission in spinal synaptic circuits following
CCD, because of excessive ectopic discharge input from
the injured LT afferents. Moreover, GABAergic interneurons
outnumber glycinergic interneurons, 35% versus 18% of the
total neuronal population, in laminae I–III of the dorsal horn
[40]. Thus, CCD-induced ectopic discharge of LT afferents
would lead to a loss for more GABAergic inhibition than
glycinergic inhibition.
It has been reported that the restoration of lumbar
intervertebral foramen space improves mechanical hyper-
sensitivity and that decompression of the DRG reduces
compression-induced decreases of DRG neurons [41]. Thus,
it is possible to expect that gradual attenuation of CCD-
induced mechanical hypersensitivity is due to the recovery
of damaged CCD neurons by the gradual widening of the
intervertebral foramen over a period of time after injury.
In clinical data, 60% of neuropathic pain patients who
had undergone surgery to enlarge narrowed foramens show
attenuation of neuropathic pain within a year [42]. Taken
together, the recovery of damaged peripheral nerves and
subsequent restoration of spinal GABAergic inhibition are
critical for the improvement of chronic neuropathic pain
following CCD.
5. Conclusions
CCD modulates spinal GABAergic inhibitory function. In
the early phase after CCD, spinal GABAergic inhibition is
reduced via the decrease of GABA content in GABA neurons,
resulting in mechanical hypersensitivity in the hind paw
and spinal neuronal hyperexcitability. In the later phase,
GABAergic inhibition level is restored to normal via recovery
of GABA content, leading to alleviation of such mechanical
hypersensitivity and neuronal hyperexcitability. Therefore,
the control of spinal GABA levels could be a useful tool for
the treatment of neuropathic pain following CCD.
Highlights
(i) GABA-ir neurons were decreased without changes in
total neuron numbers on the CCD injury side in the
early phase, whereas there were no changes in GABA-
ir neurons in the late phase.
(ii) Mechanical hypersensitivity and spinal WDR neu-
ronal hyperexcitability developed on the CCD injured
side in the early phase, which returned to normal in
the late phase.
(iii) GABA receptor agonists reduced CCD-induced me-
chanical hypersensitivity and neuronal hyperexcita-
bility in the early phase.
(iv) GABA receptor antagonists reinduced mechanical
hypersensitivity and neuronal hyperexcitability in the
late phase.
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